Short duration (≤28 days) | Prolonged duration (>28 days) | Risk ratio of >28 days | ||
N=126 (86%) | N=21 (14%) | |||
Age (mean (SD)) | 24.7 (5.4) | 24.6 (4.0) | -— | |
Gender | Male:female | 81:45 | 11:10 | -— |
Sport type | Summer sport | 116 (92%) | 20 (95%) | 1.6 (0.2 to 10.9) |
Winter sport | 10 (8%) | 1 (5%) | 0.6 (0.1 to 4.1) | |
Able-bodied sport | 106 (84%) | 16 (76%) | 0.7 (0.3 to 1.6) | |
Paralympic sport | 20 (16%) | 5 (24%) | 1.5 (0.6 to 3.8) | |
Comorbidities | No comorbidities | 98 (78%) | 15 (71%) | 0.8 (0.3 to 2.1) |
At least one comorbidity | 28 (22%) | 6 (29%) | 1.2 (0.5 to 3.1) | |
Phenotype | Upper respiratory | 50 (40%) | 4 (19%) | 0.4 (0.1 to 1.1) |
Cough | 33 (26%) | 4 (19%) | 0.7 (0.6 to 1.9) | |
Non-specific | 23 (18%) | 5 (24%) | 1.3 (0.5 to 3.3) | |
Lower respiratory | 17 (14%) | 8 (38%) | 3.0 (1.4 to 6.5)* | |
Gastrointestinal | 3 (2%) | 0 (0%) | 1.0 (0.1 to 13.1) | |
Symptoms | Fatigue | 69 (55%) | 15 (71%) | 1.1 (0.6 to 1.8) |
Dry cough | 61 (48%) | 12 (57%) | 1.0 (0.6 to 1.7) | |
Headache | 57 (45%) | 11 (52%) | 1.0 (0.5 to 1.7) | |
Fever | 51 (40%) | 9 (43%) | 0.9 (0.5 to 1.7) | |
Sore throat | 37 (29%) | 6 (29%) | 0.8 (0.4 to 1.8) | |
Myalgia/arthralgia | 38 (30%) | 4 (19%) | 0.5 (0.2 to 1.4) | |
Anosmia/dysgeusia | 29 (23%) | 5 (24%) | 0.9 (0.4 to 2.0) | |
Dyspnoea | 18 (14%) | 8 (38%) | 1.9 (1.0 to 3.6) | |
Diarrhoea | 5 (4%) | 1 (5%) | 1.0 (0.2 to 6.0) | |
Nausea | 5 (4%) | 1 (5%) | 1.0 (0.2 to 6.0) | |
Chest pain | 3 (2%) | 2 (10%) | 2.4 (0.8 to 7.2) | |
Dizziness | 3 (2%) | 1 (5%) | 1.5 (0.3 to 8.3) | |
Abdominal pain | 2 (2%) | 1 (5%) | 2.0 (0.4 to 10.1) |
Percentages are of the column subtotals.
*P=0.011.